Acknowledgement to Referees.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 323, doi. 10.1007/s40290-022-00450-y
- Publication type:
- Article
Works matching IS 11782595 AND DT 2022 AND VI 36 AND IP 6
Results: 7
1
2
Major Pharmaceutical Conferences and Courses: February to March 2023.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 401, doi. 10.1007/s40290-022-00449-5
- Publication type:
- Article
3
The Pharmaceutical Year That Was, 2022.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 327, doi. 10.1007/s40290-022-00448-6
- By:
- Publication type:
- Article
4
The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 387, doi. 10.1007/s40290-022-00447-7
- By:
- Publication type:
- Article
5
The Effectiveness and Safety of Cannabidiol in Non-seizure-related Indications: A Systematic Review of Published Randomized Clinical Trials.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 353, doi. 10.1007/s40290-022-00446-8
- By:
- Publication type:
- Article
6
Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and Geroprotection.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 331, doi. 10.1007/s40290-022-00444-w
- By:
- Publication type:
- Article
7
Correction to: The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases.
- Published in:
- Pharmaceutical Medicine, 2022, v. 36, n. 6, p. 405, doi. 10.1007/s40290-022-00440-0
- By:
- Publication type:
- Article